Vietnam has become a popular tourist destination. Visitors looking to be swept away by gorgeous landscape will be can see jungles, caves, grottoes, and immense limestone pillars. Those looking to explore new flavors and foods will be thrilled with the cheap and delicious street food. ...
Passport Health – Travel Vaccines for the Vietnam Overall rating: 5 stars – 14 reviews ★★★ “Very Informative“ “We had another great experience at Passport Health. We appreciate the customized booklet and informative session for our upcoming trip to Vietnam. All of our questions were tho...
This vaccine is recommended for people aged 9 months or older and who are traveling to or living in areas at risk (certain parts of Africa and Asia). f This is a newly developed vaccine of outer surface protein A (OspA) that is currently not available, but is undergoing the final Phase...
2]. Current influenza vaccines result in short-term, strain-specific immunity [3] which is particularly problematic in tropical and subtropical settings where multiple peaks and identifiable year-round activity make it challenging to decide if, who and when to vaccinate, as ...
Immunogenicity and safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase II, randomized, open, controlled study Pediatr Infect Dis J, 29 (2010), pp. e35-e46 CrossrefView in ScopusGoogle Scholar [15] ...
Other injectables were developed throughout the early 20th century but are not recommended by the WHO due to low levels of efficacy, short duration of protection, and unfavourable safety profiles [55,59]. The first whole-cell oral vaccine to be licensed internationally was developed at the ...
A vaccine should be safe and not immunologically interfere when coadministered with other recommended vaccines, and should be stable for two years at 2–8 °C. It should be cost-effective so that price is not a barrier to access in LMICs. The PPC document includes both oral and injectable ...
Other injectables were developed throughout the early 20th century but are not recommended by the WHO due to low levels of efficacy, short duration of protection, and unfavourable safety profiles [55,59]. The first whole-cell oral vaccine to be licensed internationally was developed at the ...
This single- dose live vaccine induces a significant immune response with ~95% seroconversion rate [9] and is recommended for immunization in age group ≥9 months and ≤18 years followed with a booster dose after 1–2 years of priming. Later on, the vaccine was recommended for adults (>18...
Due to the dearth of therapeutics, vaccination seems to be a reliable means of prevention, other than avoiding mosquito bites [144]. As part of pre-travel precaution in most countries, multiple doses of JEV vaccines are recommended [145]. Since the 1990s, significant progress has been made ...